Frances Rutledge
Family · Montgomery, ALNPI 1407415581
Payments from drug & device makers
Across 51 payments — averaging $20.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$222
- Sumitomo Pharma America, Inc.$130
- Astellas Pharma US Inc$84
- Hologic Sales And Service, LLC$81
- Baxter Healthcare$70
- Radius Health, Inc.$63
- plus $419 from 16 others
What the payments were for
- Food & beverage$1,067100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $222 |
| Sumitomo Pharma America, Inc. | 3 | $130 |
| Astellas Pharma US Inc | 2 | $84 |
| Hologic Sales And Service, LLC | 5 | $81 |
| Baxter Healthcare | 1 | $70 |
| Radius Health, Inc. | 3 | $63 |
| Scynexis, Inc. | 4 | $62 |
| Pfizer | 3 | $55 |
| Bayer | 3 | $46 |
| Medtronic | 2 | $36 |
| Channel Medsystems, Inc. | 1 | $34 |
| Dexcom, Inc. | 1 | $29 |
| Mayne Pharma Commercial LLC | 3 | $20 |
| Sage Therapeutics, LLC | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Organon | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
| Myovant Sciences Inc. | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $11 |
How this compares
$1,067 in reported general payments places this provider in the 65th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 11 | $6,197 |
| MyrbetriqMirabegron | 13 | $5,655 |
| Estradiol | 27 | $2,013 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 25 | $334 |
| Fluconazole | 31 | $241 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $130 | $6,19711 claims |
| Astellas Pharma US IncMyrbetriq | $84 | $5,65513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,415 family providers in Alabama.
Other family in Montgomery
- Leigh LunaMontgomery$69K
- Brandy YoungMontgomery$27K
- Angela RaybornMontgomery$22K
- Ashley MorrowMontgomery$21K
- Jackie ShumateMontgomery$19K
- Katrina Jones HarrisMontgomery$18K
- Brittney BarberMontgomery$12K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.